Efficacy of EGFR/PI3K signaling inhibition is enhanced with LSD1 inhibition in glioblastoma stem cell (GSC) models

被引：0
|
作者：
Stitzlein, Lea [1 ]
Luetzen, Matthew [1 ]
McCabe, Caitlin [1 ]
Khosla, Maninder [1 ]
Singh, Melissa [1 ]
Su, Xiaoping [1 ]
Lu, Yue [1 ]
Gumin, Joy [1 ]
Lang, Frederick [1 ]
Whitehead, Christopher [2 ]
Sebolt-Leopold, Judith [3 ]
Chandra, Joya [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Mekanst Therapeut, Ann Arbor, MI USA
[3] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3329
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Efficacy of LSD1 Directed Agents is Enhanced with Kinase Signaling Inhibition in Glioblastoma Stem Cells
    Stitzlein, Lea
    Adams, Jack
    Luetzen, Matthew
    Singh, Melissa
    Su, Xiaoping
    Lu, Yue
    Ezhilarasan, Ravesanker
    Gumin, Joy
    Lang, Frederick F.
    Sulman, Erik
    Chandra, Joya
    Monje-Deisseroth, Michelle
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2023, 385
  • [2] IN VITRO AND IN VIVO EFFICACY OF COMBINATORIAL INHIBITION OF LSD1 AND HDACS IN PATIENT DERIVED GLIOBLASTOMA STEM CELL MODELS
    Gangadharan, Achintyan
    Grasse, Leslie
    Espejo, Alexsandra
    Ezhilarasan, Ravesanker
    Collier, Tiara
    Henry, Verlene
    Gumin, Joy
    Sulman, Erik
    Lang, Frederick
    Chandra, Joya
    [J]. NEURO-ONCOLOGY, 2020, 22 : 103 - 104
  • [3] Generation and characterization of a glioblastoma stem cell model with acquired resistance to LSD1 inhibition
    Patel, Kareena H.
    Stitzlein, Lea
    Nam, Deokhwa
    Lang, Frederick
    Gumin, Joy
    Chandra, Joya
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [4] A Potential Role for the Inhibition of PI3K Signaling in Glioblastoma Therapy
    Stroebele, Stephanie
    Schneider, Matthias
    Schneele, Lukas
    Siegelin, Markus D.
    Nonnenmacher, Lisa
    Zhou, Shaoxia
    Karpel-Massle, Georg
    Westhoff, Mike-Andrew
    Halatsch, Marc-Eric
    Debatin, Klaus-Michael
    [J]. PLOS ONE, 2015, 10 (06):
  • [5] Evaluation of in vitro and in vivo efficacy of pharmacological lysine-specific demethylase 1 (LSD1) inhibitors in glioblastoma stem cell (GSC) models
    Stitzlein, Lea
    Gangadharan, Achintyan
    Grasse, Leslie
    Espejo, Alexsandra
    Singh, Melissa
    Lu, Yue
    Ezhilarasan, Ravesanker
    Gumin, Joy
    Sulman, Erik
    Lang, Frederick
    Chandra, Joya
    [J]. FASEB JOURNAL, 2022, 36
  • [6] Modulation of microRNA in glioblastoma, after inhibition of key signaling components of EGFR/PI3K/Akt/mTOR pathway
    Codrici, E.
    Enciu, A. M.
    Popescu, I. D.
    Albulescu, L.
    Tanase, C.
    [J]. FEBS OPEN BIO, 2022, 12 : 101 - 101
  • [7] Inhibition of LSD1 and HDACs causes synergistic cell death in glioblastoma cells
    Singh, Melissa
    Manton, Christa
    Tsai, Wen-Wei
    Barton, Michelle
    Chandra, Joya
    [J]. CANCER RESEARCH, 2010, 70
  • [8] LSD1 activates both PI3K/AKT and AR signaling in prostate cancer cells
    Wang, Zifeng
    Gao, Shuai
    Cai, Changmeng
    [J]. MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [9] Dual inhibition of EGFR and PI3K with a single drug
    Katerji, Meghri
    Rubin, Maxine R.
    Brognard, John
    [J]. NATURE CANCER, 2024, 5 (08) : 1131 - 1133
  • [10] PI3K inhibition in preclinical models of HNSCC
    Hedberg, Matthew Louis
    Li, Hua
    Zeng, Yan
    Grandis, Jennifer Rubin
    [J]. MOLECULAR CANCER THERAPEUTICS, 2015, 14 (07)
12345